Ferumoxtran-10 carbohydrate-polyethylene glycol coated

Drug Profile

Ferumoxtran-10 carbohydrate-polyethylene glycol coated

Alternative Names: Clariscan; NC 100150; PEG-Ferron

Latest Information Update: 05 Aug 2002

Price : $50

At a glance

  • Originator Amersham Health
  • Class Contrast media; Ferric compounds; Glucans; Oxides
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Vascular disorders

Most Recent Events

  • 05 Aug 2002 Discontinued - Phase-II for Vascular disorders diagnosis in European Union (Parenteral)
  • 05 Aug 2002 Discontinued - Phase-II for Vascular disorders diagnosis in USA (Parenteral)
  • 02 Jul 2002 A preclinical study has been added to the adverse events and pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top